BioRestorative Therapies Inc (BRTX)
$2.74
$-0.06
(-2.24%)
As on 09-Sep-2026 16:00EDT
Market cap
$4 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-2.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.2
-
Face value
--
-
Shares outstanding
27,622,556
10 Years Aggregate
CFO
$-49.78 Mln
EBITDA
$-132.18 Mln
Net Profit
$-139.05 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
| -88.3 | -32.8 | -62.2 | -91.5 | -57.5 | -61.2 | -68.4 |
|
BSE Sensex*
| -11.7 | -4.7 | 1.2 | -7.8 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
| -17.8 | -17.7 | -36.7 | -36.6 | -84.3 | 38.0 | -99.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
BioRestorative Therapies Inc (BRTX)
|
2.7 | 4.1 | 0.4 | -11.1 | -3,089.6 | -422.6 | -- | 1.3 |
| 82.6 | 12,161.6 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.2 | |
| 260.8 | 17,746.8 | 1,054.4 | 755.9 | 5.7 | -- | 20.9 | 10.5 | |
| 74.1 | 10,109.8 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.5 | |
| 58.3 | 14,621.6 | 2,435.9 | 860.6 | 31.0 | 43 | 18.6 | 7.9 | |
| 107.4 | 12,506.3 | 1,663.7 | 413.6 | 36.3 | 430 | 32.3 | 86.7 | |
| 348.1 | 10,603.5 | 440.5 | 241.5 | 33.4 | 18.7 | 44.9 | 8.1 | |
| 546.7 | 12,501.2 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 23.9 | |
| 586.3 | 16,503.9 | 2,782.3 | 491.5 | 21.1 | 110.1 | 34.7 | 38.2 | |
| 124.0 | 9,808.7 | 0.0 | -450.1 | -- | -44.6 | -- | 8.4 |
Shareholding Pattern
View DetailsAbout BioRestorative Therapies Inc (BRTX)
BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells. The company develops programs related to the treatment of disc/spine disease and metabolic... disorders. Its products pipeline comprises BRTX-100, a lead cell therapy candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, as well as used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure; and ThermoStem, a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. The company also operates a commercial biocosmeceutical platform. In addition, it provides investigational curved needle device to deliver cells and/or other therapeutic products or material to the spine and discs, and other parts of the body. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. is headquartered in Melville, New York. Read more
-
Chairman of the Board, President & CEO
Mr. Lance Alstodt
-
Chairman of the Board, President & CEO
Mr. Lance Alstodt
-
Headquarters
Melville, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for BioRestorative Therapies Inc (BRTX)
What is the current share price of BioRestorative Therapies Inc (BRTX) Today?
The share price of BioRestorative Therapies Inc (BRTX) is $2.74 (NASDAQ) as of 09-Sep-2026 16:00 EDT. BioRestorative Therapies Inc (BRTX) has given a return of -57.53% in the last 3 years.
What is the current PB & PE ratio of BioRestorative Therapies Inc (BRTX)?
Since, TTM earnings of BioRestorative Therapies Inc (BRTX) is negative, P/E ratio is not available.
The P/B ratio of BioRestorative Therapies Inc (BRTX) is 1.31 times as on 04-Sep-2026, a 75 discount to its peers’ median range of 5.33 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.73 |
29.24 |
2024 |
-1.24 |
1.30 |
2023 |
-0.79 |
0.82 |
2022 |
-0.76 |
0.98 |
2021 |
-0.09 |
0.18 |
What is the 52 Week High and Low of BioRestorative Therapies Inc (BRTX)?
The 52-week high and low of BioRestorative Therapies Inc (BRTX) are Rs 34.60 and Rs 2.65 as of 10-Sep-2026.
What is the market cap of BioRestorative Therapies Inc (BRTX)?
BioRestorative Therapies Inc (BRTX) has a market capitalisation of $ 4 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in BioRestorative Therapies Inc (BRTX)?
Before investing in BioRestorative Therapies Inc (BRTX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.